• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Model-based sensor-augmented pump therapy.基于模型的传感器增强型泵治疗
J Diabetes Sci Technol. 2013 Mar 1;7(2):465-77. doi: 10.1177/193229681300700224.
2
Minimizing postprandial hypoglycemia in Type 1 diabetes patients using multiple insulin injections and capillary blood glucose self-monitoring with machine learning techniques.使用多次胰岛素注射和基于机器学习技术的毛细血管血糖自我监测来最小化 1 型糖尿病患者的餐后低血糖。
Comput Methods Programs Biomed. 2019 Sep;178:175-180. doi: 10.1016/j.cmpb.2019.06.025. Epub 2019 Jun 27.
3
Insulin Sensitivity Index-Based Optimization of Insulin to Carbohydrate Ratio: In Silico Study Shows Efficacious Protection Against Hypoglycemic Events Caused by Suboptimal Therapy.基于胰岛素敏感性指数的胰岛素与碳水化合物比值优化:模拟研究表明,针对治疗不足引起的低血糖事件具有有效的保护作用。
Diabetes Technol Ther. 2018 Feb;20(2):98-105. doi: 10.1089/dia.2017.0248.
4
Assessing sensor accuracy for non-adjunct use of continuous glucose monitoring.评估用于非辅助性连续血糖监测的传感器准确性。
Diabetes Technol Ther. 2015 Mar;17(3):177-86. doi: 10.1089/dia.2014.0272. Epub 2014 Dec 1.
5
"Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.“让算法发挥作用”:在 1 型糖尿病患儿中使用带有预测性胰岛素悬浮功能(SmartGuard)的动态胰岛素泵治疗减少低血糖发生
Diabetes Technol Ther. 2017 Mar;19(3):173-182. doi: 10.1089/dia.2016.0349. Epub 2017 Jan 18.
6
Feasibility of overnight closed-loop control based on hourly blood glucose measurements.基于每小时血糖测量的夜间闭环控制的可行性。
J Diabetes Sci Technol. 2012 Jul 1;6(4):902-9. doi: 10.1177/193229681200600422.
7
A novel adaptive basal therapy based on the value and rate of change of blood glucose.一种基于血糖值及其变化率的新型自适应基础治疗方法。
J Diabetes Sci Technol. 2009 Sep 1;3(5):1099-108. doi: 10.1177/193229680900300513.
8
Hybrid Closed-Loop Insulin Delivery in Type 1 Diabetes During Supervised Outpatient Conditions.1型糖尿病患者在门诊监督条件下的混合闭环胰岛素输注
J Diabetes Sci Technol. 2016 May 3;10(3):708-13. doi: 10.1177/1932296816631568. Print 2016 May.
9
Faster insulin action is associated with improved glycaemic outcomes during closed-loop insulin delivery and sensor-augmented pump therapy in adults with type 1 diabetes.闭环胰岛素输注和传感器增强型泵治疗期间,胰岛素作用更快与 1 型糖尿病成人患者血糖控制改善相关。
Diabetes Obes Metab. 2017 Oct;19(10):1485-1489. doi: 10.1111/dom.12956. Epub 2017 Jun 23.
10
In Silico Assessment of Literature Insulin Bolus Calculation Methods Accounting for Glucose Rate of Change.考虑葡萄糖变化率的文献中胰岛素大剂量计算方法的计算机模拟评估
J Diabetes Sci Technol. 2019 Jan;13(1):103-110. doi: 10.1177/1932296818777524. Epub 2018 May 31.

本文引用的文献

1
Clinical evaluation of a personalized artificial pancreas.个性化人工胰腺的临床评估。
Diabetes Care. 2013 Apr;36(4):801-9. doi: 10.2337/dc12-0948. Epub 2012 Nov 27.
2
Pilot studies of wearable outpatient artificial pancreas in type 1 diabetes.1型糖尿病患者可穿戴式门诊人工胰腺的初步研究。
Diabetes Care. 2012 Sep;35(9):e65-7. doi: 10.2337/dc12-0660.
3
Blood glucose control in type 1 diabetes with a bihormonal bionic endocrine pancreas.双激素仿生胰腺控制 1 型糖尿病患者的血糖。
Diabetes Care. 2012 Nov;35(11):2148-55. doi: 10.2337/dc12-0071. Epub 2012 Aug 24.
4
Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia.1 型糖尿病的全集成人工胰腺:模块化闭环血糖控制可维持接近正常的血糖水平。
Diabetes. 2012 Sep;61(9):2230-7. doi: 10.2337/db11-1445. Epub 2012 Jun 11.
5
Modular closed-loop control of diabetes.糖尿病的模块化闭环控制。
IEEE Trans Biomed Eng. 2012 Nov;59(11):2986-99. doi: 10.1109/TBME.2012.2192930. Epub 2012 Apr 3.
6
Continuous glucose monitoring considerations for the development of a closed-loop artificial pancreas system.闭环人工胰腺系统开发中的连续血糖监测考量
J Diabetes Sci Technol. 2011 Nov 1;5(6):1327-36. doi: 10.1177/193229681100500603.
7
Control-relevant models for glucose control using a priori patient characteristics.使用先验患者特征进行血糖控制的控制相关模型。
IEEE Trans Biomed Eng. 2012 Jul;59(7):1839-49. doi: 10.1109/TBME.2011.2176939. Epub 2011 Nov 22.
8
Insulin pump therapy in adults.成人胰岛素泵治疗。
Diabetes Res Clin Pract. 2011 Aug;93 Suppl 1:S109-13. doi: 10.1016/S0168-8227(11)70025-0.
9
Automatic learning algorithm for the MD-logic artificial pancreas system.MD-logic 人工胰腺系统的自动学习算法。
Diabetes Technol Ther. 2011 Oct;13(10):983-90. doi: 10.1089/dia.2010.0216. Epub 2011 Jul 20.
10
Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study.STAR 3 研究中传感器增强型泵治疗在 1 型糖尿病儿童和青少年中的疗效。
Pediatr Diabetes. 2012 Feb;13(1):6-11. doi: 10.1111/j.1399-5448.2011.00793.x. Epub 2011 Jul 3.

基于模型的传感器增强型泵治疗

Model-based sensor-augmented pump therapy.

作者信息

Grosman Benyamin, Voskanyan Gayane, Loutseiko Mikhail, Roy Anirban, Mehta Aloke, Kurtz Natalie, Parikh Neha, Kaufman Francine R, Mastrototaro John J, Keenan Barry

机构信息

Medtronic Minimed Inc., 18000 Devonshire St., Northridge, CA 91325, USA.

出版信息

J Diabetes Sci Technol. 2013 Mar 1;7(2):465-77. doi: 10.1177/193229681300700224.

DOI:10.1177/193229681300700224
PMID:23567006
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3737649/
Abstract

BACKGROUND

In insulin pump therapy, optimization of bolus and basal insulin dose settings is a challenge. We introduce a new algorithm that provides individualized basal rates and new carbohydrate ratio and correction factor recommendations. The algorithm utilizes a mathematical model of blood glucose (BG) as a function of carbohydrate intake and delivered insulin, which includes individualized parameters derived from sensor BG and insulin delivery data downloaded from a patient's pump.

METHODS

A mathematical model of BG as a function of carbohydrate intake and delivered insulin was developed. The model includes fixed parameters and several individualized parameters derived from the subject's BG measurements and pump data. Performance of the new algorithm was assessed using n = 4 diabetic canine experiments over a 32 h duration. In addition, 10 in silico adults from the University of Virginia/Padova type 1 diabetes mellitus metabolic simulator were tested.

RESULTS

The percentage of time in glucose range 80-180 mg/dl was 86%, 85%, 61%, and 30% using model-based therapy and [78%, 100%] (brackets denote multiple experiments conducted under the same therapy and animal model), [75%, 67%], 47%, and 86% for the control experiments for dogs 1 to 4, respectively. The BG measurements obtained in the simulation using our individualized algorithm were in 61-231 mg/dl min-max envelope, whereas use of the simulator's default treatment resulted in BG measurements 90-210 mg/dl min-max envelope.

CONCLUSIONS

The study results demonstrate the potential of this method, which could serve as a platform for improving, facilitating, and standardizing insulin pump therapy based on a single download of data.

摘要

背景

在胰岛素泵治疗中,优化大剂量胰岛素和基础胰岛素剂量设置是一项挑战。我们引入了一种新算法,该算法可提供个性化的基础输注率以及新的碳水化合物比率和校正因子建议。该算法利用血糖(BG)作为碳水化合物摄入量和输注胰岛素的函数的数学模型,其中包括从传感器BG和从患者泵下载的胰岛素输注数据得出的个性化参数。

方法

建立了血糖作为碳水化合物摄入量和输注胰岛素的函数的数学模型。该模型包括固定参数以及从受试者的BG测量值和泵数据得出的几个个性化参数。使用4只糖尿病犬进行了32小时的实验来评估新算法的性能。此外,还对弗吉尼亚大学/帕多瓦1型糖尿病代谢模拟器中的10名虚拟成年人进行了测试。

结果

使用基于模型的治疗方法,血糖范围在80 - 180mg/dl的时间百分比,犬1至4分别为86%、85%、61%和30%,对照实验的相应结果分别为[78%,100%](方括号表示在相同治疗方法和动物模型下进行的多次实验)、[75%,67%]、47%和86%。使用我们的个性化算法在模拟中获得的BG测量值在61 - 231mg/dl分钟 - 最大值范围内,而使用模拟器的默认治疗方法得到的BG测量值在90 - 210mg/dl分钟 - 最大值范围内。

结论

研究结果证明了该方法的潜力,它可以作为一个平台,基于单次数据下载来改进、促进和规范胰岛素泵治疗。